Showing 1 - 17 results of 17 for search 'S. L. Maksimov', query time: 0.03s Refine Results
  1. 1
    A REVIEW OF CASES OF DEVELOPMENT OF ACUTE HEPATIC INSUFFICIENCY DUE TO THE INTAKE OF BIOLOGICALLY ACTIVE ADDITIVES

    A REVIEW OF CASES OF DEVELOPMENT OF ACUTE HEPATIC INSUFFICIENCY DUE TO THE INTAKE OF BIOLOGICALLY ACTIVE ADDITIVES by M. L. Maksimov, S. A. Simakova

    Published 2018-06-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    PERINDOPRIL: THE POSSIBILITY OF ANTIHYPERTENSIVE AND RENOPROTECTIVE THERAPY

    PERINDOPRIL: THE POSSIBILITY OF ANTIHYPERTENSIVE AND RENOPROTECTIVE THERAPY by O. V. Dralova, M. L. Maksimov

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    RETRACTED: An objective: to lower blood pressure effectively and safely. How to do it in a rational and modern way?

    RETRACTED: An objective: to lower blood pressure effectively and safely. How to do it in a rational and modern way? by O. V. Dralova, M. L. Maksimov

    Published 2013-03-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    COMBINATION OF DIRECT RENNIN INHIBITOR - ALISKIREN, ANGIOTENSIN II RECEPTOR BLOCKER - VALSARTAN, AND CALCIUM CHANNEL BLOCKER - AMLODIPINE, IN THERAPY OF HYPERTENSIVE PATIENT WITH GOUT (CASE REPORT)

    COMBINATION OF DIRECT RENNIN INHIBITOR - ALISKIREN, ANGIOTENSIN II RECEPTOR BLOCKER - VALSARTAN, AND CALCIUM CHANNEL BLOCKER - AMLODIPINE, IN THERAPY OF HYPERTENSIVE PATIENT WITH G... by O. V. Dralova, M. L. Maksimov

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    ACE inhibitors in arterial hypertension treatment among various clinical groups

    ACE inhibitors in arterial hypertension treatment among various clinical groups by O. D. Ostroumova, M. L. Maksimov

    Published 1970-01-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?

    ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE? by K. A. Ghyamdzhyan, M. L. Maksimov

    Published 2012-09-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    SARTANS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS: A DUEL BETWEEN TWO LEADERS OF PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES

    SARTANS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS: A DUEL BETWEEN TWO LEADERS OF PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES by K. A. Gyamdzhyan, M. L. Maksimov

    Published 2015-12-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Features of choosing the tactics and method of treatment of external joint frequencies of long external bones in people living with HIV

    Features of choosing the tactics and method of treatment of external joint frequencies of long external bones in people living with HIV by N. G. Doronin, S. N. Khoroshkov, S. L. Maksimov

    Published 2020-03-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    ADVANTAGES AND NOVELTY OF CLINICAL APPLICATION OF THE TRIPLE COMBINATION FOR ARTERIAL HYPERTENSION WITH DYSLIPIDEMIA: ACE INHIBITOR PERINDOPRIL WITH ROSUVASTATIN AND INDAPAMIDE

    ADVANTAGES AND NOVELTY OF CLINICAL APPLICATION OF THE TRIPLE COMBINATION FOR ARTERIAL HYPERTENSION WITH DYSLIPIDEMIA: ACE INHIBITOR PERINDOPRIL WITH ROSUVASTATIN AND INDAPAMIDE by M. L. Maksimov, A. S. Ermolaeva, O. V. Dralova

    Published 2017-08-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Angiotensin II type 1 receptor antagonists and ACE inhibitors in the regulation of hemodynamics and renin-angiotensin-aldosterone system activity: focus on the organ protection

    Angiotensin II type 1 receptor antagonists and ACE inhibitors in the regulation of hemodynamics and renin-angiotensin-aldosterone system activity: focus on the organ protection by M. L. Maksimov, O. V. Dralova, A. K. Starodubtsev

    Published 2010-04-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Bisoprolol effectiveness in arterial hypertension and coronary heart disease

    Bisoprolol effectiveness in arterial hypertension and coronary heart disease by O. D. Ostroumova, M. L. Maksimov, A. M. Rykova

    Published 1970-01-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION

    LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION by O. D. Ostroumova, M. L. Maksimov, I. I. Kopchenov

    Published 2015-09-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    THE PROBLEM OF MEDICINES INTERCHANGEABILITY. FOCUS ON PERINDOPRIL

    THE PROBLEM OF MEDICINES INTERCHANGEABILITY. FOCUS ON PERINDOPRIL by A. I. Malyhina, M. V. Zhuravleva, A. K. Starodubtsev, M. L. Maksimov, O. A. Rogacheva

    Published 2015-09-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    ROLE OF THE METABOLITE THERAPY FOR THE TREATMENT OF CHRONIC HEART FAILURE

    ROLE OF THE METABOLITE THERAPY FOR THE TREATMENT OF CHRONIC HEART FAILURE by L. N. Maksimova, M. L. Maksimov, Y. R. Nartsissov, R. M. Zaslavskaya, E. V. Kalinina

    Published 2015-09-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    Catheter-induced infectious endocarditis complicated by pulmonary embolism: successful surgical treatment

    Catheter-induced infectious endocarditis complicated by pulmonary embolism: successful surgical treatment by A. P. Medvedev, S. A. Fedorov, V. V. Pichugin, A. L. Maksimov, M. B. Sukhova, A. V. Bogush, Q. B. Vepaev

    Published 2020-08-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Early virologic response to сеpeginterferon alfa-2b in combination with ribavirin in treatment of patients with chronic hepatitis C

    Early virologic response to сеpeginterferon alfa-2b in combination with ribavirin in treatment of patients with chronic hepatitis C by O. O. Znoyko, M. V. Maevskaya, E. A. Klimova, S. L. Maksimov, S. N. Kizhlo, N. A. Petrochenkova, F. I. Nagimova, R. A. Ivanov, Yu. N. Linkova, T. V. Chernovskaya

    Published 2014-09-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    Prevalence of AOX1 and CYP1A2 gene polymorphisms associated with response to favipiravir therapy in novel coronavirus infection COVID-19 among ethnic groups of the North Caucasus

    Prevalence of AOX1 and CYP1A2 gene polymorphisms associated with response to favipiravir therapy in novel coronavirus infection COVID-19 among ethnic groups of the North Caucasus by A. T. Leinsoo, N. P. Denisenko, Sh. P. Abdullaev, S. N. Tuchkova, A. V. Kryukov, S. N. Mammaev, Zh. A. Sozaeva, M. S.-Kh. Sozaeva, K. A. Akmalova, L. Z. Bolieva, A. I. Dobroselskaya, M. L. Maksimov, K. B. Mirzaev, D. A. Sychev

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: